ELEVANCE HEALTH, INC. (ELV) FY2026 Q2 P&L / Income Statement

ELEVANCE HEALTH, INC. (ELV) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

50,474,000,000 US dollars

Total expenses

48,537,000,000 US dollars

Operating profit (calculated)

1,937,000,000 US dollars

Other income (expense), net (calculated)

0 US dollars

Income before income tax expense

1,937,000,000 US dollars

Income tax expense

483,000,000 US dollars

Net income

1,454,000,000 US dollars

Total operating revenue

49,826,000,000 US dollars

Net investment income

704,000,000 US dollars

Benefit expense

37,024,000,000 US dollars

Cost of products sold

5,492,000,000 US dollars

Operating expense

5,547,000,000 US dollars

Amortization of other intangible assets

110,000,000 US dollars

Interest expense

364,000,000 US dollars

Revenue before reconciliation (calculated)

50,530,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Net losses on financial instruments

negative 56,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to ELEVANCE HEALTH, INC.: $1.46 B; to noncontrolling interests: −$9.00 M.